Grant: Collaborative Health Research Projects
University of Toronto
$188,600.00
Rapid gene expression and protein profiling for transplantation medicine
EF 2014-15
Résumé
Lung transplantation (LTx) is a life-saving therapy for patients suffering from end-stage lung disease. While there have beensignificant advances in procedures for lung transplantation, there are still significant impediments that stand in the way ofsuccessful transplantation outcomes. While the number of patients in need of LTx is significantly increasing, the number ofdonors remains static. The shortage is further aggravated by very low utilization rates of donor lungs (~15%) among multiorgandonors due to the conservative practices of many transplant groups. Recently, a set of markers were identified by co-PIs Keshavjee, Liu and Cypel that provide a molecular basis for better predicting the quality of donor lungs and thustransplant outcomes. The challenge of using these molecular markers, however, is that they must be assessed rapidly inorder for this information to be used. After removal from a donor, lungs must be transplanted within 8 hours, and the clock onthe use of the lung may start at times when the services of laboratories equipped to perform molecular analysis are notavailable. An ideal solution would be an automated testing unit that could perform rapid analysis of marker levels at the sitewhere the donated organs are being assessed and retrieved. A new molecular analysis platform recently developed byKelley and Sargent will provide a solution enabling marker analysis for organ transplantation. The platform is based on anelectronic chip that is highly robust, inexpensive, and straightforward to fabricate. This project will adapt the chip-baseddetection platform described above for the challenge of transplantation medicine. The automated, highly multiplexed, fastand portable nature of this molecular diagnostic platform makes it an ideal fit for rapid readout of markers predicting lungtransplant outcomes. The primary deliverable to be obtained with this support is an integrated protein/RNA detection systemfor transplantation medicine.
Programme
Collaborative Health Research Projects
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
446513-2013
Name nom
Kelley, Shana
Department département
Pharmacy, Leslie Dan Faculty of
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2014
Competition year année de concours
2013
Award amount
188600
Program id
CHRPJ
Program name en
Collaborative Health Research Projects
Program name fr
Projets de recherche concertée sur la santé
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
360
Committee name en
Collaborative Health Research Projects Selection Panel
Committee name fr
Comité de sélection de projets de recherche concertée sur la santé
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
9999
Research subject group en
Not available
Research subject group fr
Non disponible
Research subject en
Not available
Research subject fr
Non disponible
Partie
2 & 3
Nb partie
3
Application title
Rapid gene expression and protein profiling for transplantation medicine
Keyword
NSERC
Application summary
Lung transplantation (LTx) is a life-saving therapy for patients suffering from end-stage lung disease. While there have beensignificant advances in procedures for lung transplantation, there are still significant impediments that stand in the way ofsuccessful transplantation outcomes. While the number of patients in need of LTx is significantly increasing, the number ofdonors remains static. The shortage is further aggravated by very low utilization rates of donor lungs (~15%) among multiorgandonors due to the conservative practices of many transplant groups. Recently, a set of markers were identified by co-PIs Keshavjee, Liu and Cypel that provide a molecular basis for better predicting the quality of donor lungs and thustransplant outcomes. The challenge of using these molecular markers, however, is that they must be assessed rapidly inorder for this information to be used. After removal from a donor, lungs must be transplanted within 8 hours, and the clock onthe use of the lung may start at times when the services of laboratories equipped to perform molecular analysis are notavailable. An ideal solution would be an automated testing unit that could perform rapid analysis of marker levels at the sitewhere the donated organs are being assessed and retrieved. A new molecular analysis platform recently developed byKelley and Sargent will provide a solution enabling marker analysis for organ transplantation. The platform is based on anelectronic chip that is highly robust, inexpensive, and straightforward to fabricate. This project will adapt the chip-baseddetection platform described above for the challenge of transplantation medicine. The automated, highly multiplexed, fastand portable nature of this molecular diagnostic platform makes it an ideal fit for rapid readout of markers predicting lungtransplant outcomes. The primary deliverable to be obtained with this support is an integrated protein/RNA detection systemfor transplantation medicine.